Technology | 2009.09.15
Neurologix to Showcase Novel Brain and CNS Disease Gene Therapies at BioPharm America
FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to Parkinson’s disease and other serious brain and central nervous system diseases at the BioPharm America partnering conference being held in San Francisco, CA on September 17 – 18. John Mordock, Neurologix President and
For more information, please visit
http://www.businesswire.com/news/home/20090914005935/en
